Lactic Acid Bacteria / Probiotics: Label Quantity Standards and Cross-Border Compliance Guide

---

Executive Summary

The global market for lactic acid bacteria (LAB) and probiotic dietary supplements continues to expand, bringing with it an increasingly complex compliance landscape for consumers and cross-border buyers. This paper systematically examines three dimensions of current regulatory practice: ingredient quantity labeling standards, Japan's domestic labeling regulatory framework, and key compliance considerations for cross-border purchasing. The goal is to help consumers and procurement professionals establish a verifiable, information-based framework for product evaluation. All content is strictly limited to objective dimensions — labeling, testing, ingredient origin, and traceability — and contains no claims regarding medical efficacy.

---

1. Definitions and Product Classification

Lactic acid bacteria (LAB) is a collective term for microorganisms that ferment sugars to produce lactic acid, encompassing multiple genera including *Lactobacillus*, *Bifidobacterium*, and *Streptococcus*. Probiotics is a functional concept jointly defined by the Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO) in 2001 as "live microorganisms which, when administered in adequate amounts, confer a health benefit on the host." This definition is a scientific classification, not a product efficacy claim.

In the market, LAB-based products are regulated across three primary categories:

• General Foods: No functional claims permitted. Labels may only state ingredient names and quantities, subject to the basic labeling requirements of the *Food Labeling Act* (*Shokuhin Hyoji Ho*, *Shokuhin Hyoji Kijun*).
• Foods with Function Claims (Kino-sei Hyoji Shokuhin): Established in 2015, this system requires companies to file supporting scientific evidence with the Consumer Affairs Agency (CAA) before using approved functional claim language on packaging. Unlike FOSHU, this is a notification-based system rather than an individual approval process.
• Foods for Specified Health Uses (FOSHU / Tokutei Hoken-yo Shokuhin): Requires individual approval from the CAA; the authorization number must appear on the packaging. This is the most rigorously regulated category within Japan's health food system.

Identifying which regulatory category a product belongs to is the essential first step in interpreting its label.

---

2. Ingredient Quantity Labeling Standards: Key Metrics Explained

2.1 Strain-Level Identification

Internationally recognized best practices for probiotic labeling — as set out in FAO/WHO guidelines and the International Scientific Association for Probiotics and Prebiotics (ISAPP) position statements — require identification to the strain level, not merely the genus or species. For example:

• Insufficient labeling: *Bifidobacterium* spp.
• Adequate labeling: *Bifidobacterium longum* BB536 (BB536 is a proprietary strain registered by Meiji Co., Ltd.; cited here as a format example only)

Strain-level identification matters because biological characteristics vary substantially between strains. Consumers and researchers rely on strain information to locate publicly available literature and safety data — a fundamental requirement of labeling transparency.

2.2 CFU Notation and Reference Point

Viable cell counts are expressed as CFU (Colony Forming Units). Labels may state CFU at one of two reference points, and the distinction is material:

The notification rules for Foods with Function Claims and the voluntary quality standards of industry bodies such as the Japan Health and Nutrition Food Association (JHNFA) encourage manufacturers to declare a guaranteed viable count at the best-before date, ensuring that labeling accurately reflects the product's condition at the time of actual consumption.

2.3 Viability Assurance Conditions

Viable cell counts are directly dependent on storage conditions. A compliant label should clearly state the storage temperature requirements under which the declared CFU count is guaranteed (e.g., refrigeration required, room temperature acceptable, protect from light) as well as the recommended period of use after opening. Without this information, consumers cannot assess whether the declared cell count was maintained under the required conditions throughout the supply chain.

2.4 Quantity Labeling for Other Ingredients

In addition to CFU counts, LAB products frequently contain prebiotics (such as inulin and oligosaccharides), vitamins, and minerals. Under Japan's *Food Labeling Act* and the *Nutrition Labeling Standards*, the nutrition facts panel must display energy, protein, fat, carbohydrate, and sodium in the prescribed format as mandatory items. Additional ingredients may be voluntarily declared based on product characteristics, but all stated values must be supported by analytical data; false or unsubstantiated declarations are prohibited.

---

3. Japan's Domestic Labeling Compliance Framework

3.1 Principal Regulatory Statutes

Health food labeling in Japan is governed by an interlocking body of legislation:

• Food Labeling Act (Shokuhin Hyoji Ho, effective 2015): Consolidates food labeling provisions formerly spread across the *JAS Act*, the *Food Sanitation Act*, and the *Health Promotion Act*. This is the primary labeling statute currently in force. Violations may result in administrative penalties and fines.
• Health Promotion Act (Kenko Zoshin Ho): Prohibits exaggerated representations of health effects in food products. Representations that differ materially from the facts (*ichijirushiku jijitsu ni soigoto suru hyoji*) are unlawful.
• Act against Unjustifiable Premiums and Misleading Representations (Keihintyo Keihinhyoji Ho): Administered by the CAA, this statute targets "misleading superiority representations" (*yuryo gonin hyoji*) — that is, representations that lead consumers to believe a product is of higher quality than it actually is. Enforcement measures include corrective orders and administrative surcharges.

3.2 GMP Certification and Manufacturing Traceability

Manufacturing quality is the foundation of labeling credibility. At the industry level, the JHNFA operates a GMP Conformity Certification program under which manufacturing facilities are subject to third-party audits covering raw material management, manufacturing processes, quality inspection, and distribution controls. Certified facilities are issued a certification number and are subject to periodic review and unannounced inspections.

Consumers can cross-reference a product's stated JHNFA certification number against the association's publicly available list of certified facilities to verify the facility's certification status and validity period. This is a concrete, verifiable indicator of a manufacturer's quality management standards.

3.3 Mandatory Labeling Requirements Checklist

Under the current *Food Labeling Act*, labels for LAB-based health foods sold in Japan must include (non-exhaustively):

• 1. Product name
• 2. Ingredient list (including additives, in descending order by weight)
• 3. Net quantity or drained weight
• 4. Expiration date or best-before date
• 5. Storage instructions
• 6. Manufacturer name and address (for imported products, importer information must also be included)
• 7. Nutrition facts panel (energy and five core nutrients)
• 8. Allergen declarations (7 ingredients mandatory; 21 ingredients recommended)
• 9. For Foods with Function Claims, the following additional items are required: notification reference number (todoke-de bango), functional claim text (as approved in the filed notification), and prescribed disclaimer language — including that the product is not intended for the diagnosis, treatment, or prevention of any disease

---

4. Cross-Border Purchase Compliance Considerations

4.1 Product Classification and Destination-Country Regulatory Mapping

A product that is lawfully marketed in Japan must still satisfy the regulatory requirements of any destination country before it can be sold there. Using mainland China as an example:

Standard General Trade Import (Direct Import): LAB-based health foods bearing functional health claims for sale in China must be registered with the State Administration for Market Regulation (SAMR) under the *Administrative Measures for the Registration and Filing of Health Food* (first-time imports require registration; subsequent products may qualify for filing). Products must carry -language labels that have been reviewed and approved by the relevant authority. Products that have not completed registration or filing may not be sold domestically under the health food designation.

Cross-Border E-Commerce Channel: Under China's *Cross-Border E-Commerce Retail Import Commodity List* (the "positive list") and related regulations, products purchased through licensed cross-border e-commerce platforms for personal use are subject to a separate regulatory framework from general trade. However, annual individual purchase limits currently apply (RMB 26,000), along with per-transaction caps, and resale is prohibited. The buyer, as an individual consumer, bears compliance responsibility.

United States Market: LAB-based products are generally classified as dietary supplements and regulated under the *Dietary Supplement Health and Education Act* (DSHEA, 1994). Labels must include a Supplement Facts panel. Any product bearing a structure/function claim must also carry the standard FDA disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." Structure/function claims must be substantiated and notified to the FDA within 30 days of going to market.

European Union Market: Under the *Food Supplements Directive* (Directive 2002/46/EC) and the *Health Claims Regulation* (EC No. 1924/2006), no generic health claims for probiotics have been authorized at the EU level. Manufacturers may not attach functional claims to the term "probiotics" on product labels or in advertising; doing so constitutes a regulatory violation. Member states retain some differences in national rules.

4.2 Label Language Compliance for Cross-Border Purchases

Most countries require that foods sold domestically be labeled in the official national language. The compliant pathways for -labeled products entering the market include:

• Cross-Border E-Commerce for Personal Use: No mandatory -language label is currently required on the physical product, but platforms must provide -language product information on their websites.
• General Trade Import: A compliant -language label must be affixed. Label content is subject to regulatory review, and unauthorized translation or addition of unapproved functional claims is prohibited.

Consumers acquiring products through informal gray-market or personal-shopper channels should be aware that such arrangements may exceed the scope of personal use and thus risk non-compliance, and that they will not have access to the after-sale service and quality assurance available through legitimate channels.

4.3 Customs Inspection Priorities

Customs authorities in most markets focus cross-border health food inspections on the following:

• Whether the ingredient list contains substances that are prohibited or subject to quantity restrictions in the destination country (e.g., specific additives, certain botanical extracts)
• Whether complete ingredient declaration documents are included (e.g., Certificate of Analysis, COA)
• Whether the declared strains appear on the destination country's approved or recognized safety list
• Whether product labeling meets destination-country requirements

Consumers are advised to verify the admissibility status of the specific probiotic strains in the destination country before purchasing. Certain countries impose explicit restrictions on strains of specific genera.

---

5. Practical Guidance for Consumers

The following is a step-by-step checklist derived from the compliance framework above. Consumers can work through these points before making a purchase:

• 1. Verify strain-level identification: Confirm that the label specifies strains to the full three-tier level (genus + species + strain designation) rather than using a generic descriptor such as "lactic acid bacteria."
• 2. Clarify the CFU reference point: Distinguish between CFU at time of manufacture and CFU at the best-before date. Products that expressly guarantee a CFU count at the best-before date provide more informative labeling.
• 3. Match storage requirements to actual shipping conditions: If a product requires refrigeration but the purchasing process involves long-distance international transit with no documented cold-chain record, the potential impact on the declared cell count should be carefully considered.
• 4. Verify the manufacturing facility's certification status: For products, the JHNFA certification number or equivalent third-party certification number printed on the packaging can be used to check the facility's current certification status on the certifying body's official website.
• 5. Confirm product classification and claims compliance: If a product carries a functional claim as a Food with Function Claims, the corresponding notification reference number can be looked up in the CAA's Foods with Function Claims database to view the approved claim language and confirm that the label text matches the filed notification.
• 6. Understand destination-country import rules: Before purchasing cross-border, confirm that the product category falls within the scope of what is admissible in the destination country, and assess whether the intended purchase quantity falls within applicable personal-use limits.
• 7. Confirm availability of batch-level test reports (COA): Reputable manufacturers are generally able to provide batch-specific test reports issued by independent third-party laboratories. Consumers and procurement professionals may request these reports to verify that measured cell counts align with label declarations.

---

Closing Remarks

Compliant labeling for lactic acid bacteria and probiotic products is ultimately an expression of information transparency. Accurate strain-level identification, a verifiable viable cell count guarantee, and labeling logic that is consistent with stated storage conditions together constitute the factual foundation that enables consumers to make rational, informed comparisons at the point of purchase. Cross-border purchasing introduces additional layers of complexity: divergent destination-country regulatory frameworks, channel compliance requirements, and label language obligations.

When evaluating products from varied sources, the most effective protection available to consumers is to return to verifiable, objective information: certification numbers that can be checked, notification records that can be searched, and batch reports that can be requested. Any product for which this basic information cannot be provided should be treated with appropriate caution, regardless of the claims appearing on its label. The compliance framework described in this paper is based on regulations currently in effect; where relevant rules are updated, the most recent versions published by the responsible authorities shall take precedence.

---

*This document is provided for informational purposes only and does not constitute legal advice. For specific compliance matters, please consult a qualified food regulatory professional or the relevant competent authority in your jurisdiction.*